Investment
Features
FeesSafety
Academy
More
Pluang+

Compare F5 Inc (FFIV) vs Moderna, Inc. (MRNA) Price & Performance

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

F5 Inc vs Moderna, Inc. — how do they compare? F5 Inc trades at $414 (market cap $23.44B), while Moderna, Inc. trades at $60.33 (market cap $24.18B). The key difference: F5 Inc and Moderna, Inc. are close in size by market cap, and F5 Inc is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

FFIVMRNA
Market Cap
$23.44B$24.18B
Sector
TechnologyHealth
52-Week High
$431.26$81.80
52-Week Low
$223.99$22.36
Enterprise Value
$22.08B$20.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

F5 Inc

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $59.81, up 1.08% today, with a bullish technical signal from moving averages and recent FDA approval for its mRNA flu vaccine mFLUSIVA. Despite beating Q2 2026 EPS estimates, revenue has declined from pandemic peaks, with a net income margin of -142.58% in 2026. The stock faces resistance near $61-$63, while support lies at $56-$59.

Outlook remains mixed; pipeline advancements in flu, Ebola, and oncology offer growth potential, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $54.33 price target below current levels, reflecting concerns over profitability amid transitioning business focus.

Returns comparison

Trailing returns across standard periods

About F5 Inc

F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.

Read more on FFIV

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA